LAVA-1207
lava therapeutics
['crpc', 'gu ', '$lvtx', 'lava therap']
lava therapeutics announces initial data from the ongoing phase 1/2a clinical trial of lava-1207 in therapy refractory mcrpc at the 2023 asco gu symposium $lvtx 
Real-Time News, Market Data and Stock Quotes for Biotech, Pharma, and Healthcare Stocks